Suchergebnisse - "Kennedy, Nicholas A"

PubPharm (18)

1

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

enthalten in: Gastroenterology | 2023

von Liu, Z. | Alexander, J. | Lin, K. | +70

2

Systemic Inflammation in Preclinical Ulcerative Colitis

enthalten in: Gastroenterology | 2021

von Bergemalm, D. | Andersson, E. | Hultdin, J. | +53

3

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease

enthalten in: Gastroenterology | 2020

von Sazonovs, A. | Kennedy, N. | Moutsianas, L. | +119

4

Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases

enthalten in: Gastroenterology | 2018

von Clerc, F. | Novokmet, M. | Dotz, V. | +57

5

Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases

enthalten in: Gastroenterology | 2018

von Šimurina, M. | de Haan, N. | Vučković, F. | +63

6

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease

enthalten in: Gastroenterology | 2015

von Torres, J. | Boyapati, R. | Kennedy, N. | +3

7

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease

enthalten in: Gastroenterology | 2015

von Torres, J. | Boyapati, R. | Kennedy, N. | +3

8

Beyond gene discovery in inflammatory bowel disease : the emerging role of epigenetics

enthalten in: Gastroenterology | 2013

von Ventham, N. | Kennedy, N. | Nimmo, E. | +1

9

Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics

enthalten in: Gastroenterology | 2013

von Ventham, N. | Kennedy, N. | Nimmo, E. | +1

10

564 Elevated Faecal Calprotectin Predicts Disease Progression in Crohns Disease

enthalten in: Gastroenterology | 2013

von Kennedy, N. | Chang, J. | Guy, M. | +12